Treatment of hepatitis B virus-associated membranous nephropathy: Lamivudine era versus post-lamivudine era

Korean Journal of Internal Medicine

Volumn 27, Issue 4, 2012, Pages 394-396

  Moon, Ju Young ^a   Lee, Sang Ho ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADEFOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; CLEVUDINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC AGENT; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; RITUXIMAB; TELBIVUDINE; THYMUS EXTRACT; VIRUS DNA;

ACUTE HEPATITIS; ANTIVIRAL RESISTANCE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG SUBSTITUTION; EDEMA; EDITORIAL; ELECTRON MICROSCOPY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NEPHROTOXICITY; NONHUMAN; PROTEINURIA; SEROCONVERSION; SEROLOGY; TREATMENT OUTCOME; VIRUS LIKE AGENT; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANTIVIRAL AGENTS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE;

EID: 84871795263     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2012.27.4.394     Document Type: Editorial

References (10)

1. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004;24:198-211.
2. Liao MT, Chang MH, Lin FG, Tsai IJ, Chang YW, Tsau YK. Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 2011;128:e600-e604.
3. Lai KN, Li PK, Lui SF, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-1463.
4. Yi Z, Jie YW, Nan Z. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: a systematic review and meta-analysis. Ann Hepatol 2011;10:165-173.
5. Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol 2012;18:821-832.
6. Sun IO, Hong YA, Park HS, et al. Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including lamivudine-resistant strains. Korean J Intern Med 2012;27:411-416.
7. Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354:1001-1010.
8. Ebata S, Hashimoto S, Suzuki A, et al. A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease. Clin Exp Nephrol 2012;16:805-810.
9. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990;54:12-17.
10. Shin SK, Ryu DR, Hwang JH, et al. Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B. Korean J Nephrol 1999;18:550-559.